Points to consider on clinical investigation of medicinal products for treatment of rheumatoid arthritis.
fibrin sealants Note for guidance on the Clinical investigation of von Willebrand factor Warning on transmissible agents for patient leaflets and SPCs Core SPC for Plasma derived fibrin sealants